Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-02-01, Stock:LLY, The news for the past five days is as follows:
2021-01-25: NEWS1: Will Eli Lilly (LLY) Beat Estimates This Earnings Season?.
2021-01-26: NEWS1: Coronavirus update: J&J to release vaccine data next week; strain from Brazil confirmed in US.NEWS2: New data show treatment with etesevimab (JS016) and bamlanivimab together reduced risk of COVID-19 hospitalizations and death by 70 percent.NEWS3: Eli Lilly and Regeneron Report More Positive Data on Covid-19 Antibody Cocktails.NEWS4: Regeneron's (REGN) Performance Strong in 2020: What Lies Ahead?.NEWS5: Lilly says late-stage study showed combo therapy can reduce deaths and hospitalizations in COVID-19 patients.NEWS6: General Electric, Johnson & Johnson - Tuesday's Premarket Movers.NEWS7: The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market.NEWS8: Eli Lilly Shares Gain After Positive Data From Late-Stage Covid Treatment Trial.NEWS9: New data show treatment with Lilly's neutralizing antibodies bamlanivimab (LY-CoV555) and etesevimab (LY-CoV016) together reduced risk of COVID-19 hospitalizations and death  by 70 percent.
2021-01-27: NEWS1: Lilly's (LLY) Bamlanivimab Combo Lowers COVID-19 Hospitalization.NEWS2: Vir Will Test Its Covid-19 Antibody With Eli Lilly’s, Sending Shares Up Again.NEWS3: The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement.NEWS4: Lilly, Vir Biotechnology and GSK announce first patient dosed in expanded BLAZE-4 trial evaluating bamlanivimab (LY-CoV555) with VIR-7831 (GSK4182136) for COVID-19.NEWS5: Eli Lilly’s Antibody Therapy Cuts Covid-19 Hospitalization By 70%.NEWS6: Eli Lilly, Regeneron's COVID-19 treatments may be weaker against South Africa variant-study.
2021-01-28: NEWS1: Drugmakers examine effectiveness of COVID-19 vaccines and treatments against new, more infectious South African strain.NEWS2: 5 Big Pharma/Biotech Stocks Set to Trump Q4 Earnings Estimates.NEWS3: Lilly (LLY) Partners Vir/Glaxo for COVID-19 Combo Regimen.NEWS4: Eli Lilly's Earnings: A Preview.NEWS5: Regeneron (REGN) COVID-19 Cocktail Effective Against New Variants.NEWS6: Is a Surprise Coming for Lilly (LLY) This Earnings Season?.NEWS7: Lilly, Life for a Child and Beyond Type 1 advance partnership to improve diabetes care in resource-limited countries.NEWS8: Lilly and Asahi Kasei Pharma Announce License Agreement for Chronic Pain Drug Candidate.
2021-01-29: NEWS1: Eli Lilly & Co (LLY) Q4 2020 Earnings Call Transcript.NEWS2: Eli Lilly Tops Estimates With Government Purchases of Covid Treatment.NEWS3: This Pharma Stock Just Returned To A Profit-Taking Zone On Its Earnings Beat.NEWS4: The new South African strain is more infectious, and it’s also making COVID-19 vaccines less effective.NEWS5: Lilly Reports Strong Sales, Boosted by Covid Antibodies.NEWS6: This Pharma Stock Is Now Trading Above A Profit Zone And At A Record High.NEWS7: Personal Income Increased in December.NEWS8: Economic Prints, Q4 Reports Up for Lilly, CAT; J&J Posts Phase-3 Data.NEWS9: Pharma Stock Roundup: JNJ, NVS Q4 Earnings, MRK & LLY's Coronavirus Updates.NEWS10: Eli Lilly (LLY) Q4 Earnings Top, COVID-19 Antibody Boosts Sales.NEWS11: REFILE-US STOCKS-Wall St set to open lower after J&J vaccine data.NEWS12: Eli Lilly Shares Gain Over 4% After Profit Beat; Target Price $225.NEWS13: Can Eli Lilly and Regeneron Antibody Treatments Beat New COVID Strains?.NEWS14: Recap: Eli Lilly Q4 Earnings.NEWS15: Eli Lilly Stock Rises Near Highs As Lilly Earnings Beat Views.NEWS16: Eli Lilly beats profit and sales forecasts, to deliver 500,000 more COVID-19 treatment doses by end of March.NEWS17: Eli Lilly profit beats estimates on demand for cancer, diabetes drugs.NEWS18: Lilly Reports Strong Fourth-Quarter and Full-Year 2020 Financial Results.NEWS19: Johnson & Johnson, Lilly, Caterpillar, Chevron - Friday's Premarket Movers.NEWS20: GameStop Surges, Musk Lifts Bitcoin; Euro GDP - What's up in Markets.NEWS21: Eli Lilly Tops Q4 Earnings Forecast, Sees COVID Therapies Sales Boost in 2021.

Answer: Decrease